By Lisa Kerner
Charlotte, N.C., Oct. 23 - Sadra Medical completed a $19 million series B round of funding.
Proceeds will be used to begin clinical evaluation of the Sadra Lotus Valve for percutaneous aortic valve replacement within the next several months, officials said.
New investors Oakwood Medical Investors and Boston Scientific Corp. joined previous investors Pequot Ventures, Onset Ventures and SV Life Sciences Advisors in the financing.
Sadra is a privately held, development-stage company based in Campbell, Calif.
| Issuer: | Sadra Medical
|
| Issue: | Series B financing
|
| Amount: | $19 million
|
| Investors: | Oakwood Medical Investors, Boston Scientific Corp., Pequot Ventures, Onset Ventures, SV Life Sciences Advisors
|
| Announcement date: | Oct. 23
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
